BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26524567)

  • 21. Lentigo maligna successfully treated with imiquimod.
    du Plessis PJ
    S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
    [No Abstract]   [Full Text] [Related]  

  • 22. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials.
    Astorino S; Astorre P; Pasquini P; Di Nunno D; Pellegrini F; Paolino G
    Dermatol Ther; 2019 Jan; 32(1):e12757. PubMed ID: 30285299
    [No Abstract]   [Full Text] [Related]  

  • 24. Amelanotic lentigo maligna.
    Sanz de Galdeano C; Manrique P; Alvarez JA; Gonzalez MR; Calderón MJ; Zabala R; Garciandia C
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):83-5. PubMed ID: 9731976
    [No Abstract]   [Full Text] [Related]  

  • 25. Amelanotic lentigo maligna melanoma.
    Kaufmann R; Nikelski K; Weber L; Sterry W
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):339-42. PubMed ID: 7829736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
    Lorentzen HF; Weismann K
    Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy.
    Brand FL; Seyed Jafari SM; Hunger RE
    Dermatology; 2019; 235(2):150-155. PubMed ID: 30554198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
    Arlette JP; Trotter MJ; Trotter T; Temple CL
    J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should topical imiquimod be used for positive margins in lentigo maligna?
    Wang TS; Griffiths CC; Roman EM
    J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
    [No Abstract]   [Full Text] [Related]  

  • 30. Amelanotic lentigo maligna melanoma: report of a case and review of the literature.
    Rocamora V; Puig L; Romaní J; de Moragas JM
    Cutis; 1999 Jul; 64(1):53-6. PubMed ID: 10431675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod as an antiaging agent.
    Metcalf S; Crowson AN; Naylor M; Haque R; Cornelison R
    J Am Acad Dermatol; 2007 Mar; 56(3):422-5. PubMed ID: 17184874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bedside diagnosis of lentigo maligna with reflectance confocal microscopy.
    Zubair R; Haroon A; Rao B
    J Cutan Pathol; 2018 Jul; 45(7):553-555. PubMed ID: 29693252
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
    Chapman MS; Spencer SK; Brennick JB
    Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical usefulness of reflectance confocal microscopy in the management of facial lentigo maligna melanoma.
    Alarcón I; Carrera C; Puig S; Malvehy J
    Actas Dermosifiliogr; 2014 Apr; 105(3):e13-7. PubMed ID: 24657027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
    Fisher GH; Lang PG
    Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
    [No Abstract]   [Full Text] [Related]  

  • 37. Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors.
    Guitera P; Haydu LE; Menzies SW; Scolyer RA; Hong A; Fogarty GB; Gallardo F; Segura S
    Br J Dermatol; 2014 Jun; 170(6):1305-12. PubMed ID: 24641247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive lentigo maligna clearing with topical imiquimod.
    Epstein E
    Arch Dermatol; 2003 Jul; 139(7):944-5. PubMed ID: 12873903
    [No Abstract]   [Full Text] [Related]  

  • 39. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentigo maligna: review of salient characteristics and management.
    Kallini JR; Jain SK; Khachemoune A
    Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.